Search
for
Sort by
Research 151–180 of 1000+
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Dermatological manifestations of COVID-19 and its therapies: a review
- The role of androgen and androgen receptor in skin-related disorders
- Sarcoidosis: Are there differences in your skin of color patients?
- Alopecia areata treated with topical minoxidil
- Telogen effluvium after oral albendazole
- Dermatologic Care of the Transplant Patient
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- Topical minoxidil for nail growth: A conventional medication with a novel indication
- 1399 Efficacy of platelet-rich plasma combination treatments in dermatology: A systematic review
- 증례 : 몸통의 다발성 판으로 나타난 Bortezomib에 의한 약물 발진 2예
- Alopecia secondary to severe discoid lupus responding to anifrolumab
- Atypical bilateral hyperpigmented macules on the lower legs possibly due to cyclophosphamide.
- The pharmacology of methotrexate
- Telogen Effluvium due to Recombinant Interferon α-2b
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Nasal sporotrichosis in children
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- 576 INTASYL PH-762: Intratumoral immunotherapy targeting PD-1
- Sorafenib-induced Facial Acneiform Eruption
- Injudicious Use of Topical Steroids, A Misconcept in Treatment of Patients with Acne Vulgaris -
- Comparison of The Efficacy and Safety of Topical 2% Minoxidil and 5% Minoxidil Solution in Fingernail Growth Rate
- Retinoids
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- Oral Presentations
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study